{"nct_id":"NCT01352793","title":"A Global Phase 3 Safety Study of 120 mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 Years","status":"COMPLETED","status_verified_date":"2015-02","start_date":"2012-11","start_date_type":null,"primary_completion_date":"2014-09","primary_completion_date_type":"ACTUAL","completion_date":"2014-09","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["PFE"]}